# ICG and Blue Dye Guided Sentinel Lymph Node Biopsy in Patients Underwent Neoadjuvant Therapy

> **NCT02869815** · — · UNKNOWN · sponsor: **Peking University People's Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Breast Neoplasms

## Interventions

- **PROCEDURE:** ICG+Methylene Blue

## Key facts

- **NCT ID:** NCT02869815
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08
- **Primary completion:** 2019-08
- **Final completion:** 2020-08
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2019-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02869815

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02869815, "ICG and Blue Dye Guided Sentinel Lymph Node Biopsy in Patients Underwent Neoadjuvant Therapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02869815. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*